USA - engelsk - NLM (National Library of Medicine)

baxter healthcare corporation - leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), lysine hydrochloride (unii: jnj23q2com) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), histidine (unii: 4qd397987e) (histidine - unii:4qd397987e), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (un - leucine 730 mg in 100 ml - travasol is indicated as a source of amino acids for patients requiring parenteral nutrition when oral or enteral nutrition is not possible, insufficient, or contraindicated. travasol may be used to treat negative nitrogen balance in patients. the use of travasol is contraindicated in: risk summary limited published data with injectable amino acids solutions, including travasol in pregnant women are not sufficient to inform a drug associated risk for adverse developmental outcomes. however, malnutrition in pregnant women is associated with adverse maternal and fetal outcomes [see clinical considerations]. animal reproduction studies have not been conducted with injectable amino acids solutions, including travasol. the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. however, the background risk in the u.s. general population of major birth defects is 2 to 4% and of miscar

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6) - lysine 1.18 g in 100 ml

Armenien - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

liqvor cjsc - glycine - solution for irrigation - 15mg/ml

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

glycine -

USA - engelsk - NLM (National Library of Medicine)

professional complementary health formulas - l-glycine 4x, 7x, 12x - for the temporary relief of tiredness, general weakness, muscle fatigue, sleep disturbance, minor joint pain or stiffness, diminished memory, mood changes, or indigestion.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

USA - engelsk - NLM (National Library of Medicine)

professional complementary health formulas - l-glycine 15x, 20x, 30x, 60x, 200x - for the temporary relief of tiredness, general weakness, muscle fatigue, sleep disturbance, minor joint pain or stiffness, diminished memory, mood changes, or indigestion.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Australien - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

virbac (australia) pty ltd - glycine - unknown - glycine amino acid-glycine active 0.0 - active constituent

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77) - isoleucine 990 mg in 100 ml

USA - engelsk - NLM (National Library of Medicine)

b. braun medical inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77), leucine (unii: gmw67qnf9c) (leucine - unii:gmw67qnf9c), lysine acetate (unii: ttl6g7liwz) (lysine - unii:k3z4f929h6), methionine (unii: ae28f7pnpl) (methionine - unii:ae28f7pnpl), phenylalanine (unii: 47e5o17y3r) (phenylalanine - unii:47e5o17y3r), threonine (unii: 2zd004190s) (threonine - unii:2zd004190s), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), valine (unii: hg18b9yrs7) (valine - unii:hg18b9yrs7), cysteine hydrochlo - isoleucine 0.49 g in 100 ml - trophamine® is indicated for the nutritional support of infants (including those of low birth weight) and young pediatric patients requiring tpn via either central or peripheral infusion routes. parenteral nutrition with trophamine® is indicated to prevent nitrogen and weight loss or treat negative nitrogen balance in infants and young pediatric patients where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal absorption of protein is impaired; or (3) protein requirements are substantially increased as with extensive burns. dosage, route of administration, and concomitant infusion of non-protein calories are dependent on various factors, such as nutritional and metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance. see warnings , precautions, pediatric use , and dosage and administration . central venous infusion should b

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - isoleucine (unii: 04y7590d77) (isoleucine - unii:04y7590d77) - isoleucine 620 mg in 100 ml